News & Updates

Neutrophils release more cytokines in DM, HFpEF patients
Neutrophils release more cytokines in DM, HFpEF patients
27 Jul 2022

In patients with type 2 diabetes mellitus (DM) or heart failure with preserved ejection fraction (HFpEF), neutrophils seem to secrete more cytokines, contributing to low-grade chronic inflammation, a recent study reports.

Neutrophils release more cytokines in DM, HFpEF patients
27 Jul 2022
Short-course quinolones, pivmecillinam on par with standard regimens in uncomplicated cystitis
Short-course quinolones, pivmecillinam on par with standard regimens in uncomplicated cystitis
27 Jul 2022 byJairia Dela Cruz

For women with acute uncomplicated cystitis, treatment regimens that include third- and fourth-generation quinolones and pivmecillinam can be administered in shorter courses, which perform similarly to the currently recommended regimens in terms of achieving symptomatic cure, according to the results of a meta-analysis presented at the 37th Annual European Association of Urology (EAU) Congress.

Short-course quinolones, pivmecillinam on par with standard regimens in uncomplicated cystitis
27 Jul 2022
Growth hormone reduces liver fat, fibro-inflammation in obese/overweight adults with NAFLD
Growth hormone reduces liver fat, fibro-inflammation in obese/overweight adults with NAFLD
27 Jul 2022 byAudrey Abella

In adults with overweight/obesity and nonalcoholic fatty liver disease (NAFLD), daily administration of growth hormone (GH) reduced hepatic steatosis and improved markers of hepatic inflammation and fibrosis, a study has shown.

Growth hormone reduces liver fat, fibro-inflammation in obese/overweight adults with NAFLD
27 Jul 2022
Gut microbiota altered in prostate cancer
Gut microbiota altered in prostate cancer
27 Jul 2022 byTristan Manalac

Men with prostate cancer have altered gut microbiota composition, according to a study presented at the recent Annual Congress of the European Association of Urology (EAU 2022). This association may partly explain the documented links between lifestyle or geographic location and prostate cancer.

Gut microbiota altered in prostate cancer
27 Jul 2022
High-risk endometrial cancer outcomes not compromised with minimally invasive vs open surgery
High-risk endometrial cancer outcomes not compromised with minimally invasive vs open surgery
27 Jul 2022

In the treatment of endometrial cancer patients with high-risk histology, minimally invasive surgery neither worsens cancer prognosis nor contributes to a significant increase in the risks of recurrence and mortality as compared with open surgery, according to a systematic review and meta-analysis.

High-risk endometrial cancer outcomes not compromised with minimally invasive vs open surgery
27 Jul 2022